Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

Daniel Aletaha, Valerie Nell, Tanja Stamm et al. · Arthritis Research & Therapy · 2005 · 1.1K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

Josef S Smolen, FC Breedveld, Michael Schiff et al. · Lara D. Veeken · 2003 · 1.1K citations

Medicine, Clinical Sciences, Internal Medicine +12

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.

Anke M. van Gestel, Jennifer J. Anderson, Piet L. C. M. van Riel et al. · PubMed · 1999 · 250 citations

Medicine, Clinical Sciences, Internal Medicine +17

Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan

T. Matsui, A. Kaneko, Jinju Nishino et al. · Annals of the Rheumatic Diseases · 2007 · 220 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

Assessing remission in clinical practice

Michael Mierau, Monika Schoels, G Gonda et al. · Lara D. Veeken · 2007 · 205 citations · Full text

Medicine, Pharmacotherapy, Pediatric Rheumatology +10